Milestone Analyses of Immune Checkpoint Inhibitors, Targeted Therapy, and Conventional Therapy in Metastatic Non–Small Cell Lung Cancer Trials: A Meta-analysis

IMPORTANCE: Novel intermediate end points may be useful to detect signals of early activity and prioritize new therapies to treat patients with advanced malignant neoplasms, including metastatic non–small cell lung cancer (mNSCLC). OBJECTIVE: To explore milestone rate, a proposed intermediate end po...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Oncol
Main Authors: Blumenthal, Gideon M., Zhang, Lijun, Zhang, Hui, Kazandjian, Dickran, Khozin, Sean, Tang, Shenghui, Goldberg, Kirsten, Sridhara, Rajeshwari, Keegan, Patricia, Pazdur, Richard
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2017
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5824222/
https://ncbi.nlm.nih.gov/pubmed/28617920
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2017.1029
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados